Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Ethyl Bromide | HCID 6332 | — |
| Reactant | HCID 21715768 | HCID 21715768 | — |
| Reactant | Potassium tert-butoxide | HCID 23665647 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | Uracel, 3-ethyl- | HCID 165291 | — |
Reaction Steps
13.47 g (40 mM) of 6amino-1-(4-chlorobenzyl)-5-isobutyrylaminouracil were dissolved in 130 ml of DMF, treated at 5° C. with 4.57 g (40.8 mM) potassium t-butoxide and after dissolution, 3.28 ml (44 mM) of ethylbromide added. After 3 hr another 1.14 g of t-BuOK and 1.64 ml of ethylbromide were added. After a further 1.5 hr, 1.64 ml of ethylbromide were supplemented. After a total of 22 hr the solution was neutralized with 1N HCl to pH 7 and the solvents evaporated in vacuo. The residue was taken up in dichloromethane-water and the organic phase collected giving 17.66 of crude 3-ethyl uracil, which was dissolved in 17.6 ml of 1N NaOH and heated under reflux for 1 hr. The solution was treated twice with 1 g of charcoal, filtered and neutralized with 5N HCl to pH 7. The solid was diluted with water, collected, and dried. The crude material was recrystallized from methanol to give 7.42 g (49.2%) of 3-(4-chlorobenzyl)-1-ethyl-8-isopropyl-xanthine, mp 221-2° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05977119 |
|---|
| Source dataset | uspto-grants-1999_11 |
|---|
| ORD ID | ord-ea909eb5c3934c6080954d741b265079 |
|---|
| Source note | uspto-grants-1999_11 |
|---|